Main Category: Cardiovascular / Cardiology
Also Included In: Pediatrics / Children’s Health; Stem Cell Research
Article Date: 11 Oct 2013 – 1:00 PDT
In the future, Dr. Kunisaki envisions being able to deliver amniotic stem cells to babies with congenital heart defects soon after delivery. The cells would then begin to regenerate damaged tissue into a healthy heart or could serve to augment heart operations. This treatment could help newborn infants stay alive without a transplant.
“Babies have to rely on mom and the placenta for everything. After they’re born, they have to rely on their own hearts to function,” Dr. Kunisaki explained. “The ideal situation is to have heart stem cells available when they are born. We diagnose heart defects at about 20 weeks gestation. That timeframe gives five months or so to generate heart cells to use at birth.”
* Centers for Disease Control and Prevention. Congenital Heart Defects – Data and Statistics
Contact Our News Editors
Next steps and ultimate goals
Amniotic stem cells, however, contain the same genetic makeup as the fetus. Therefore, this approach eliminates the possibility of the newborn infant’s body rejecting the cells. And these cells are easily obtainable from amniocentesis, a standard prenatal genetic test in which fluid is extracted from the amniotic sac.
Beginning in the last quarter of 2011, Dr. Kunisaki and his team obtained amniotic fluid samples from eight pregnant women. They extracted a type of cell called mesenchymal stromal cells, which are the most common type of cell in amniotic fluid.
American College of Surgeons. “Regenerating defective heart tissue in babies using amniotic stem cells.” Medical News Today. MediLexicon, Intl., 11 Oct. 2013. Web.
12 Oct. 2013. <http://www.medicalnewstoday.com/releases/267263.php>
Babies with congenital heart defects often go through multiple heart operations or even a transplant before their first birthday. But Shaun Kunisaki, MD, a pediatric surgeon and assistant professor of surgery at the University of Michigan, and his surgical team are testing a new method of regenerating defective heart tissue so that one day these multiple operations may no longer be necessary.
The next step was to transform those cells into induced pluripotent stem cells with the exact genetic makeup of the fetus. This step involved genetically reprogramming the cells to be, similar to embryonic stem cells, flexible enough to morph into any cell in the human body – such as the heart muscle.
Cardiac stem cells, which are in the heart, have also been considered, but the heart contains a very limited number of these stem cells.
“We know that the baby’s heart cells are functioning, but the muscle has developed abnormally,” lead study author Dr. Kunisaki said. “We have to find the right source of new cells to replace the damaged cells or generate new tissue to augment the damaged heart.”
Morphing into heart muscle cells
Current ratings for:
Regenerating defective heart tissue in babies using amniotic stem cells
The researchers’ laboratory process of transforming amniotic fluid cells into beating heart cells took just under 12 weeks. The next step is to move the study to a mouse model, which Dr. Kunisaki estimates will begin in 2014. The ultimate step will be testing the procedure on an actual baby.
Until now embryonic stem cells have shown potential to morph into various types of organ tissues, but the ethics surrounding the process of having to destroy the embryo to achieve this outcome has drawn controversy.
After three weeks in a culture, Dr. Kunisaki and his team observed the amniotic stem cells transform into heart muscle cells. The team confirmed that the cells were indeed heart cells with an antibody test, which has signature proteins that only bind to certain types of cells – in this case, the newly grown heart cells. “And you could see these cells beating in the culture dish,” he added.
Stem Cell Shortfalls
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Stem cells from bone marrow have also seemed promising, but such cells are obviously hard to obtain from a fetus. Furthermore, getting bone marrow from a donor brings about the same risk as having a heart transplant – having to suppress the newborn infant’s immune system so that its body doesn’t reject the foreign cells. “Also, bone marrow cells are not made to function like heart muscle cells, but rather to protect against inflammation,” Dr. Kunisaki explained.
cardiovascular / cardiology section for the latest news on this subject.
